Seeing the potential
We are building a global ophthalmic franchise to develop and bring to market much-needed treatments for retinal disease.
Precisely engineered solutions
We combine our innovative ocular administration and drug formulation technology to transform retinal treatments.


Oxular’s development pipeline includes treatments for prevalent retinal diseases, such as diabetic macular edema and aged related macular degeneration, plus programs for rare and orphan conditions, including ocular cancers, and delivery of gene therapy.

Our approach aims to minimize frequency of treatments, improve delivery, and reduce side effects, while increasing therapeutic effectiveness. - About Us
Scroll to Top